Company Filing History:
Years Active: 2016-2020
Title: Innovations of Alan Jonason
Introduction
Alan Jonason is a notable inventor based in Pittsford, NY (US). He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patents. With a total of four patents to his name, Jonason is recognized for his work in developing therapeutic methods that target specific molecular pathways.
Latest Patents
Among his latest patents is the use of semaphorin-4D binding molecules for treating neurodegenerative disorders. This patent outlines methods for alleviating symptoms in subjects suffering from such disorders. The approach involves administering an effective amount of an isolated binding molecule that specifically binds to semaphorin-4D (SEMA4D) or its Plexin-B1 or Plexin-B2 receptors. This innovative method holds promise for improving the quality of life for individuals affected by neurodegenerative conditions.
Career Highlights
Alan Jonason is currently associated with Vaccinex, Inc., where he continues to advance his research in the field. His work has garnered attention for its potential impact on treatment options for neurodegenerative diseases. Jonason's dedication to innovation is evident in his ongoing efforts to develop effective therapeutic strategies.
Collaborations
Some of his notable coworkers include Ernest S Smith and Maurice Zauderer. Their collaborative efforts contribute to the dynamic research environment at Vaccinex, Inc., fostering advancements in the field of neurodegenerative disorder treatments.
Conclusion
Alan Jonason's contributions to the field of neurodegenerative disorders through his innovative patents and research at Vaccinex, Inc. highlight his commitment to improving patient outcomes. His work exemplifies the importance of innovation in addressing complex medical challenges.